Biotechnology: Biological Products (No Diagnostic Substances)

Management ChangeApr 10, 2026, 04:06 PM

Vir Biotechnology CMO Mark Eisner to Step Down

AI Summary

Vir Biotechnology, Inc. announced that Mark Eisner, MD, MPH, Executive Vice President and Chief Medical Officer, will be stepping down from his role. His departure is effective April 24, 2026. The company has begun the search for a new Chief Medical Officer.

Key Highlights

Mark Eisner, MD, MPH, Executive Vice President and Chief Medical Officer, is stepping down.
His resignation is effective April 24, 2026.
Vir Biotechnology has initiated a search for a successor.

View SEC Filing

VIR

Biotechnology: Biological Products (No Diagnostic Substances)

Vir Biotechnology, Inc.

Price Impact